Disulfiram, a clinically approved agent for alcohol dependence, has been reported to inhibit GSDMD-mediated pore function [30], whereas the small-molecule compound LDC7559 was initially proposed to block GSDMD-dependent NET release [16]. This evidence concerns the gene GSDMD and alcohol dependence.